PATENT CLAIM ANALYSIS

Application Number: 15977023
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "353000"]

Abstract:
Mitigation of long and short-term detrimental effects of exposure to low dose ionizing radiation by administration of genistein in the form of a nanosuspension to a mammal in an amount effective for achieving genistein serum levels of between 1-5 μM in the mammal throughout a time period from exposure to the ionizing radiation to twelve hours after exposure to the ionizing radiation.

Claim (Index 6):
The method of  claim 2  wherein the mammal is a human.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 93.0
- Lexical Diversity: 1.575
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13856909', '15450628', '10229274', '15492801', '12284841']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7190013959878298
- 35 USC 102 Novelty (BERT): 0.5258338177726072
- Combined Prediction Score: 0.6996846381663075
- Mean Citation Score: 208.985388
- Max Citation Score: 272.12448
- Similarity Product: 161.3384135192299

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test